Trade Clover Health Investments - CLOV CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.0105 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Prev. Close* | 0.7867 |
Open* | 0.7935 |
1-Year Change* | -5.69% |
Day's Range* | 0.7777 - 0.8017 |
52 wk Range | 0.71-1.63 |
Average Volume (10 days) | 6.68M |
Average Volume (3 months) | 145.96M |
Market Cap | 477.06M |
P/E Ratio | -100.00K |
Shares Outstanding | 487.64M |
Revenue | 2.42B |
EPS | -0.47 |
Dividend (Yield %) | N/A |
Beta | 1.91 |
Next Earnings Date | Feb 26, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 27, 2024 | 0.7867 | 0.0094 | 1.21% | 0.7773 | 0.8016 | 0.7767 |
Mar 26, 2024 | 0.7735 | -0.0152 | -1.93% | 0.7887 | 0.8005 | 0.7734 |
Mar 25, 2024 | 0.7852 | -0.0131 | -1.64% | 0.7983 | 0.8263 | 0.7742 |
Mar 22, 2024 | 0.8167 | -0.0402 | -4.69% | 0.8569 | 0.8572 | 0.8167 |
Mar 21, 2024 | 0.8629 | -0.0211 | -2.39% | 0.8840 | 0.8985 | 0.8474 |
Mar 20, 2024 | 0.8682 | 0.0448 | 5.44% | 0.8234 | 0.8848 | 0.8001 |
Mar 19, 2024 | 0.8250 | 0.0464 | 5.96% | 0.7786 | 0.8303 | 0.7763 |
Mar 18, 2024 | 0.7811 | 0.0037 | 0.48% | 0.7774 | 0.8186 | 0.7438 |
Mar 15, 2024 | 0.7778 | 0.0475 | 6.50% | 0.7303 | 0.7997 | 0.7188 |
Mar 14, 2024 | 0.7221 | -0.0914 | -11.24% | 0.8135 | 0.8135 | 0.7167 |
Mar 13, 2024 | 0.7966 | -0.0318 | -3.84% | 0.8284 | 0.8583 | 0.7667 |
Mar 12, 2024 | 0.7606 | -0.0361 | -4.53% | 0.7967 | 0.7967 | 0.7467 |
Mar 11, 2024 | 0.7737 | -0.0318 | -3.95% | 0.8055 | 0.8247 | 0.7737 |
Mar 8, 2024 | 0.8005 | 0.0044 | 0.55% | 0.7961 | 0.8183 | 0.7867 |
Mar 7, 2024 | 0.7934 | -0.0228 | -2.79% | 0.8162 | 0.8162 | 0.7860 |
Mar 6, 2024 | 0.7967 | -0.0069 | -0.86% | 0.8036 | 0.8132 | 0.7829 |
Mar 5, 2024 | 0.7957 | -0.0265 | -3.22% | 0.8222 | 0.8311 | 0.7957 |
Mar 4, 2024 | 0.8398 | -0.0275 | -3.17% | 0.8673 | 0.8677 | 0.8135 |
Mar 1, 2024 | 0.8561 | -0.0091 | -1.05% | 0.8652 | 0.8734 | 0.8443 |
Feb 29, 2024 | 0.8204 | -0.0463 | -5.34% | 0.8667 | 0.8827 | 0.8204 |
Clover Health Investments Events
Time (UTC) | Country | Event |
---|---|---|
Tuesday, May 7, 2024 | ||
Time (UTC) 10:59 | Country US
| Event Q1 2024 Clover Health Investments Corp Earnings Release Q1 2024 Clover Health Investments Corp Earnings ReleaseForecast -Previous - |
Thursday, June 6, 2024 | ||
Time (UTC) 15:00 | Country US
| Event Clover Health Investments Corp Annual Shareholders Meeting Clover Health Investments Corp Annual Shareholders MeetingForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total revenue | 3476.69 | 1472 | 0 | 0 |
Total Operating Expense | 3824.28 | 2108.99 | 6.8621 | 0.01763 |
Other Operating Expenses, Total | 3359.78 | 1662 | 6.8621 | 0.01763 |
Operating Income | -347.598 | -636.992 | -6.8621 | -0.01763 |
Net Income Before Taxes | -338.844 | -587.756 | -6.74484 | -0.01763 |
Net Income After Taxes | -338.844 | -587.756 | -6.74484 | -0.01763 |
Net Income Before Extra. Items | -338.844 | -587.756 | -6.74484 | -0.01763 |
Net Income | -338.844 | -587.756 | -6.74484 | -0.01763 |
Income Available to Common Excl. Extra. Items | -338.844 | -587.756 | -6.74484 | -0.01763 |
Income Available to Common Incl. Extra. Items | -338.844 | -587.756 | -6.74484 | -0.01763 |
Diluted Net Income | -338.844 | -587.756 | -6.74484 | -0.01763 |
Diluted Weighted Average Shares | 476.244 | 412.922 | 103.5 | 75 |
Diluted EPS Excluding Extraordinary Items | -0.71149 | -1.42341 | -0.06517 | -0.00024 |
Dividends per Share - Common Stock Primary Issue | 0 | |||
Diluted Normalized EPS | -0.76047 | -1.42341 | -0.06517 | -0.00024 |
Interest Income (Expense), Net Non-Operating | 8.784 | 62.917 | 0.11726 | |
Revenue | 3476.69 | 1472 | ||
Selling/General/Admin. Expenses, Total | 486.642 | 445.745 | ||
Depreciation / Amortization | 1.187 | 1.246 | ||
Other, Net | -0.03 | -13.681 | ||
Unusual Expense (Income) | -23.326 |
Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | |
---|---|---|---|---|---|
Total revenue | 513.628 | 527.775 | 898.791 | 856.817 | 846.7 |
Revenue | 513.628 | 527.775 | 898.791 | 856.817 | 846.7 |
Total Operating Expense | 542.435 | 600.381 | 982.628 | 930.732 | 949.427 |
Selling/General/Admin. Expenses, Total | 104.87 | 129.422 | 124.349 | 117.974 | 117.531 |
Depreciation / Amortization | 0.999 | 0.279 | 0.616 | 0.586 | |
Other Operating Expenses, Total | 431.816 | 470.68 | 881.605 | 812.142 | 831.31 |
Operating Income | -28.807 | -72.606 | -83.837 | -73.915 | -102.727 |
Interest Income (Expense), Net Non-Operating | -0.007 | 0 | -0.206 | -1.384 | -1.617 |
Other, Net | 0 | -0.003 | -0.009 | -0.018 | |
Net Income Before Taxes | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 |
Net Income After Taxes | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 |
Net Income Before Extra. Items | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 |
Net Income | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 |
Income Available to Common Excl. Extra. Items | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 |
Income Available to Common Incl. Extra. Items | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 |
Diluted Net Income | -28.814 | -72.606 | -84.046 | -75.308 | -104.362 |
Diluted Weighted Average Shares | 479.164 | 478.805 | 478.148 | 477.69 | 476.062 |
Diluted EPS Excluding Extraordinary Items | -0.06013 | -0.15164 | -0.17577 | -0.15765 | -0.21922 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
Diluted Normalized EPS | -0.05022 | -0.15164 | -0.22456 | -0.15765 | -0.21922 |
Unusual Expense (Income) | 4.75 | -23.326 | 0 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Total Current Assets | 624.997 | 752.546 | 28.3029 | 0 |
Cash and Short Term Investments | 435.263 | 627.868 | 28.0032 | 0 |
Cash | 28.0032 | 0 | ||
Total Assets | 808.62 | 950.804 | 856.42 | 0.10035 |
Other Long Term Assets, Total | 15.735 | 10.432 | 0 | 0.10035 |
Total Current Liabilities | 431.507 | 372.624 | 33.934 | 0.11798 |
Accrued Expenses | 25.789 | 18.206 | 5.12778 | 0.11798 |
Notes Payable/Short Term Debt | 0 | 0 | 0.80621 | 0 |
Total Liabilities | 451.733 | 415.39 | 62.914 | 0.11798 |
Total Long Term Debt | 0 | 19.938 | 0 | 0 |
Total Equity | 356.887 | 535.414 | 793.506 | -0.01763 |
Common Stock | 0.046 | 0.046 | 788.509 | 0 |
Additional Paid-In Capital | 2319.16 | 2154.19 | 11.76 | 0 |
Retained Earnings (Accumulated Deficit) | -1946.43 | -1616.74 | -6.76247 | -0.01763 |
Total Liabilities & Shareholders’ Equity | 808.62 | 950.804 | 856.42 | 0.10035 |
Total Common Shares Outstanding | 478.394 | 470.852 | 103.5 | 75 |
Prepaid Expenses | 18.146 | 9.409 | 0.29967 | |
Long Term Investments | 138.11 | 175.939 | 828.117 | |
Other Current Liabilities, Total | 373.273 | 326.289 | 28 | |
Other Liabilities, Total | 20.226 | 18.925 | 28.98 | |
Preferred Stock - Non Redeemable, Net | 0 | 0 | ||
Cash & Equivalents | 103.791 | 299.968 | ||
Short Term Investments | 331.472 | 327.9 | ||
Total Receivables, Net | 147.158 | 62.324 | ||
Other Current Assets, Total | 24.43 | 52.945 | ||
Property/Plant/Equipment, Total - Net | 9.778 | 7.654 | ||
Property/Plant/Equipment, Total - Gross | 9.966 | |||
Accumulated Depreciation, Total | -2.312 | |||
Intangibles, Net | 20 | 4.233 | ||
Payable/Accrued | 32.445 | 28.129 | ||
Long Term Debt | 19.938 | |||
Minority Interest | 3.903 | |||
Treasury Stock - Common | -6.509 | -0.147 | ||
Other Equity, Total | -9.374 | -1.934 |
Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
---|---|---|---|---|---|
Total Current Assets | 915.7 | 1128.93 | 1274.26 | 624.997 | 1459.99 |
Cash and Short Term Investments | 567.33 | 601.926 | 496.926 | 435.263 | 723.628 |
Cash & Equivalents | 299.014 | 310.079 | 190.562 | 103.791 | 382.869 |
Short Term Investments | 268.316 | 291.847 | 306.364 | 331.472 | 340.759 |
Total Receivables, Net | 316.465 | 506.793 | 687.479 | 147.158 | 667.872 |
Other Current Assets, Total | 16.679 | 4.964 | 72.956 | 24.43 | 50.676 |
Total Assets | 1059.8 | 1258 | 1453.59 | 808.62 | 1557.68 |
Property/Plant/Equipment, Total - Net | 8.192 | 8.484 | 8.656 | 9.778 | 6.785 |
Intangibles, Net | 19.19 | 19.46 | 20 | 20 | 4.233 |
Long Term Investments | 102.192 | 86.492 | 135.873 | 138.11 | 71.907 |
Other Long Term Assets, Total | 14.523 | 14.633 | 14.801 | 15.735 | 14.762 |
Total Current Liabilities | 718.696 | 907.758 | 1110.37 | 431.507 | 1128.35 |
Payable/Accrued | 35.296 | 39.919 | 47.452 | 32.445 | 37.735 |
Accrued Expenses | 26.001 | 21.397 | 32.168 | 25.789 | 21.636 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 657.399 | 846.442 | 1030.75 | 373.273 | 1068.97 |
Total Liabilities | 737.945 | 927.427 | 1130.48 | 451.733 | 1165.7 |
Total Long Term Debt | 0 | 0 | 0 | 0 | 19.965 |
Long Term Debt | 0 | 19.965 | |||
Minority Interest | 0 | ||||
Other Liabilities, Total | 19.249 | 19.669 | 20.108 | 20.226 | 17.388 |
Total Equity | 321.852 | 330.57 | 323.107 | 356.887 | 391.98 |
Preferred Stock - Non Redeemable, Net | |||||
Common Stock | 0.047 | 0.046 | 0.046 | 0.046 | 0.046 |
Additional Paid-In Capital | 2428.1 | 2395 | 2358.62 | 2319.16 | 2280.7 |
Retained Earnings (Accumulated Deficit) | -2089.32 | -2047.85 | -2019.04 | -1946.43 | -1871.54 |
Other Equity, Total | -5.072 | -6.715 | -7.031 | -9.374 | -10.76 |
Total Liabilities & Shareholders’ Equity | 1059.8 | 1258 | 1453.59 | 808.62 | 1557.68 |
Total Common Shares Outstanding | 487.242 | 483.638 | 482.625 | 478.394 | 477.921 |
Prepaid Expenses | 15.226 | 15.245 | 16.898 | 18.146 | 17.816 |
Note Receivable - Long Term | |||||
Treasury Stock - Common | -11.902 | -9.908 | -9.491 | -6.509 | -6.467 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | |
---|---|---|---|---|
Net income/Starting Line | -338.844 | -587.756 | -6.74484 | -0.01763 |
Cash From Operating Activities | -203.926 | -282.326 | -2.22712 | -0.01763 |
Cash From Financing Activities | -4.962 | 925.393 | 858.23 | 0.01763 |
Financing Cash Flow Items | 0 | 666.241 | -0.77635 | 0.01763 |
Issuance (Retirement) of Stock, Net | -4.962 | 290.077 | 830.025 | 0 |
Issuance (Retirement) of Debt, Net | 0 | -30.925 | 28.9817 | 0 |
Net Change in Cash | -113.755 | 207.62 | 28.0032 | 0 |
Non-Cash Items | 129.656 | 111.511 | -0.11726 | |
Changes in Working Capital | 4.075 | 192.673 | 4.63498 | |
Cash From Investing Activities | 95.133 | -435.447 | -828 | |
Other Investing Cash Flow Items, Total | 99.6 | -434.724 | -828 | |
Cash From Operating Activities | 1.187 | 1.246 | ||
Capital Expenditures | -4.467 | -0.723 |
Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -72.606 | -338.844 | -254.798 | -179.49 | -75.49 |
Cash From Operating Activities | 79.032 | -203.926 | 5.442 | -96.213 | -57.042 |
Cash From Operating Activities | 0.279 | 1.187 | 2.028 | 1.412 | 0.826 |
Non-Cash Items | 37.694 | 129.656 | 114.339 | 71.399 | 28.229 |
Changes in Working Capital | 113.665 | 4.075 | 143.873 | 10.466 | -10.607 |
Cash From Investing Activities | 10.181 | 95.133 | 82.477 | 125.866 | 36.513 |
Capital Expenditures | -0.251 | -4.467 | -0.59 | -0.331 | -0.158 |
Other Investing Cash Flow Items, Total | 10.432 | 99.6 | 83.067 | 126.197 | 36.671 |
Cash From Financing Activities | -2.134 | -4.962 | -5.018 | -5.15 | -5.608 |
Financing Cash Flow Items | 0 | 0 | 0 | ||
Issuance (Retirement) of Stock, Net | -2.134 | -4.962 | -5.018 | -5.15 | -5.608 |
Issuance (Retirement) of Debt, Net | 0 | 0 | 0 | ||
Net Change in Cash | 87.079 | -113.755 | 82.901 | 24.503 | -26.137 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Clover Health Investments Company profile
Clover Health Investments, Corp. operates as a Medicare Advantage insurer in the United States. The company through its software platform provides preferred provider organization and health maintenance organization health plans for Medicare-eligible consumers. Clover Health Investments, Corp. was founded in 2014 and is headquartered in Franklin, Tennessee.Industry: | Managed Healthcare (NEC) |
3401 Mallory Lane, Suite 210
Suite 320
FRANKLIN
TENNESSEE 37067
US
Income Statement
- Annual
- Quarterly
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com